OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 105, Issue 7, Pages 1137-1145 (1 July 1998)


View previous. 13 of 45 View next.

The advanced glaucoma intervention study (AGIS): 3. baseline characteristics of black and white patients

The AGIS InvestigatorsCorresponding Author Information

Received 3 October 1997; accepted 31 December 1997.

Abstract 

Objective

The purpose of this report is to examine the differences at baseline in demographic, medical, and ophthalmic characteristics between blacks and whites enrolled in the Advanced Glaucoma Intervention Study (AGIS), a multicenter, randomized, clinical trial.

Design

Multicenter, randomized, controlled trial.

Participants

A total of 332 black patients (451 eyes), 249 white patients (325 eyes), and 10 patients of other races (13 eyes) with open-angle glaucoma that could not be controlled by medical therapy alone participated.

Intervention

There was no intervention performed.

Methods

The investigators compare the baseline demographic, medical, and ophthalmic characteristics of black and white patients, adjusting the comparisons for age and gender.

Results

Blacks in the study were younger than whites and had more systemic hypertension and diabetes than whites. The visual field defects of blacks on average were substantially more severe than those of whites. Intraocular pressures and visual acuity scores were similar in the two groups. Blacks were more hyperopic and had relatively fewer disk rim hemorrhages than whites.

Conclusions

The findings of the current study concur with those of previous clinical studies of open-angle glaucoma that visual field defects are more severe in blacks than whites.

Corresponding Author InformationReprint requests to E. Kenneth Sullivan, PhD, AGIS Coordinating Center, The EMMES Corporation, 11325 Seven Locks Road, Suite 214, Potomac, MD 20854, USA

 Supported by grants from the National Eye Institute, National Institutes of Health, U.S. Department of Health and Human Services (grant numbers 2 U10 EY06824 through 2 U10 EYO6827, 2 U10 EY06830 through 2 U10 EY06835, 2 U10 EY07057, and 7 U10EY09640).

 The writing team for this report is Eve J. Higginbotham, MD, Fred Ederer, MA, FACE, E. Kenneth Sullivan, PhD, Paul C. Van Veldhuisen, MS, Douglas E. Gaasterland, MD, Eydie Miller, MD, M. Angela Vela, MD, and Sriram Sonty, MD. Members of the Advanced Glaucoma Intervention Study are listed in the Appendix at the end of AGIS Report 4 in this issue of Ophthalmology.

PII: S0161-6420(98)97012-9

doi:10.1016/S0161-6420(98)97012-9


View previous. 13 of 45 View next.